These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 17619899)

  • 21. Typhlitis as a presenting manifestation of acute myelogenous leukemia.
    D'Souza S; Lindberg M
    South Med J; 2000 Feb; 93(2):218-20. PubMed ID: 10701793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An unusual initial manifestation of acute leukemia.
    Desai A; Desai A; Staszewski H; Cunha BA
    Am J Med; 2012 Dec; 125(12):1173-4. PubMed ID: 23062401
    [No Abstract]   [Full Text] [Related]  

  • 23. Laryngeal chloroma heralding relapse of acute myeloid leukemia.
    Hoover AC; Anderson CM; Hoffman HT; de Magalhaes Silverman M; Syrbu SI; Smith MC
    J Clin Oncol; 2014 Mar; 32(7):e18-21. PubMed ID: 24419134
    [No Abstract]   [Full Text] [Related]  

  • 24. Fludarabine, cytarabine, granulocyte colony-stimulating factor, and idarubicin (FLAG-IDA) for the treatment of children with poor-prognosis acute leukemia: the Hacettepe experience.
    Tavil B; Aytac S; Balci YI; Unal S; Kuskonmaz B; Yetgin S; Gurgey A; Tuncer M; Gumruk F; Uckan D; Cetin M
    Pediatr Hematol Oncol; 2010 Oct; 27(7):517-28. PubMed ID: 20677923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results.
    Pigneux A; Perreau V; Jourdan E; Vey N; Dastugue N; Huguet F; Sotto JJ; Salmi LR; Ifrah N; Reiffers J
    Haematologica; 2007 Oct; 92(10):1327-34. PubMed ID: 18024370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Systemic mastocytosis associated with acute myeloid leukaemia.
    Fong C; Tong M
    Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
    [No Abstract]   [Full Text] [Related]  

  • 27. Genital ulcers as diagnostic clue for acute myeloid leukaemia.
    Schröder SD; Krause SW; Erfurt-Berge C
    Int Wound J; 2018 Oct; 15(5):845-848. PubMed ID: 29683259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The expression of DeltaNTP73, TATP73 and TP53 genes in acute myeloid leukaemia is associated with recurrent cytogenetic abnormalities and in vitro susceptibility to cytarabine cytotoxicity.
    Lucena-Araujo AR; Panepucci RA; dos Santos GA; Jácomo RH; Santana-Lemos BA; Lima AS; Garcia AB; Araújo AG; Falcão RP; Rego EM
    Br J Haematol; 2008 Jul; 142(1):74-8. PubMed ID: 18422993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acceleration of leukaemia with granulocyte colony-stimulating factor in a patient with aleukaemic leukaemia.
    Fata F; Myers P; Addeo J; Nawabi I
    Br J Hosp Med; 1997 Jul 9-Aug 19; 58(2-3):111-2. PubMed ID: 9349378
    [No Abstract]   [Full Text] [Related]  

  • 30. Reticulate Hyperpigmentation secondary to 5-fluorouracil and idarubicin.
    Jogi R; Garman M; Pielop J; Orengo I; Hsu S
    J Drugs Dermatol; 2005; 4(5):652-6. PubMed ID: 16167426
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Deoxycytidine kinase is downregulated under hypoxic conditions and confers resistance against cytarabine in acute myeloid leukaemia.
    Degwert N; Latuske E; Vohwinkel G; Stamm H; Klokow M; Bokemeyer C; Fiedler W; Wellbrock J
    Eur J Haematol; 2016 Sep; 97(3):239-44. PubMed ID: 26613208
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutrophilic eccrine hidradenitis masquerading as facial cellulitis.
    Srivastava M; Scharf S; Meehan SA; Polsky D
    J Am Acad Dermatol; 2007 Apr; 56(4):693-6. PubMed ID: 17109994
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Decitabine. Acute myeloid leukaemia: no progress.
    Prescrire Int; 2014 Apr; 23(148):92-4. PubMed ID: 24860891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neutrophilic dermatoses with acute myeloid leukemia associated with an increase of serum colony-stimulating factor.
    Uhara H; Saida T; Nakazawa H; Ito T
    J Am Acad Dermatol; 2008 Aug; 59(2 Suppl 1):S10-2. PubMed ID: 18625369
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Standard-dose of idarubicin in combination with continuous infusion of cytarabine as induction therapy in patients with acute myeloid leukaemia].
    Qian SX; Li JY; Wu HX; Lu H; Qiu HX; Chen LJ; Lu RN; Xu W; Sheng RL
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):209-13. PubMed ID: 19236781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient.
    Voigt M; Sinn K; Malouhi A; Gecks T; Zinke J; Hilgendorf I; Scholl S; Hochhaus A; Schnetzke U
    Ann Hematol; 2021 Jul; 100(7):1895-1897. PubMed ID: 33443593
    [No Abstract]   [Full Text] [Related]  

  • 37. [Observation and care in high-dose cytarabine treatment of acute myelogenous leukemia].
    Xi YR; Tu YL; Zhao XH
    Zhonghua Hu Li Za Zhi; 1996 Nov; 31(11):653-5. PubMed ID: 9304928
    [No Abstract]   [Full Text] [Related]  

  • 38. Occurrence and therapy of secondary acute myeloid leukaemia in two HIV-infected patients.
    Hengge UR; Schultewolter T; Uppenkamp T
    AIDS; 1998 Jan; 12(2):221-2. PubMed ID: 9468375
    [No Abstract]   [Full Text] [Related]  

  • 39. Inappropriate antidiuretic hormone production by leukaemic blasts in acute myeloid leukaemia.
    Kobayashi K; Yokote T; Nakayama S; Takubo T; Tsuji M; Hanafusa T
    Br J Haematol; 2009 Jun; 145(5):554. PubMed ID: 19120357
    [No Abstract]   [Full Text] [Related]  

  • 40. An uncommon cause of small bowel obstruction: isolated primary granulocytic sarcoma.
    Kumar B; Bommana V; Irani F; Kasmani R; Mian A; Mahajan K
    QJM; 2009 Jul; 102(7):491-3. PubMed ID: 19433489
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.